Pj. Mroczkowski et al., Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis, CLIN EXP RH, 17(6), 1999, pp. S66-S68
An open-label, one-year study was conducted to evaluate the safety and clin
ical response to leflunomide and methotrexate combination therapy for rheum
atoid arthritis. Study results revealed tolerable safety, no significant ph
armacokinetic interactions between methotrexate and leflunomide, and sugges
ted improved clinical reponse with combination therapy.